Compound Summary
Compound Information
药名: | nobiletin |
别名: | Spectrum4_001020; 38664-96-9; 7-(2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-2,3-dihydro-4',5,7-trihydroxyflavone; CHEBI:28819; UNII-N7TD9J649B; MCULE-5348711723; SDCCGMLS-0066776.P001; N7TD9J649B; cid_442428; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4-chromenone; 5-Hydroxy-2-(4-hydroxyphenyl)-7-(2-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)-4-chromanon; EINECS 233-566-4; (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; Naringenin 7-Rhamnoglucoside; 30552-25-1; BSPBio_000574; NCGC00142617-03; MEGxp0_000930; HMS2231M18; J10148; GTPL4738; CS-5632; BDBM50241582; NCGC00142617-02; CCG-208591; 10236-47-2; 7-(2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-2,3-dihydro-4,5,7-trihydroxyflavone;Naringin; (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; AIDS-003056; HY-N0153; (2S)-7-[(2S,4S,5S,3R,6R)-3-((2S,6S,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4, 5,6-tetrahydropyran-2-yloxy))-4,5-dihydroxy-6-(hydroxymethyl)(2H-3,4,5,6-tetra hydropyran-2-yloxy)]-5-hydroxy-2-(4-hydrox; MLS000574877; 30174-44-8; NCI60_041691; Naringenine-7-rhamnosidoglucoside; NSC618903; Naringenin 7-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside; DTXSID6022478; STOCK1N-40898; ACon1_000139; (S)-7-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yloxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; N2371; AIDS003056; naringin; Prestwick2_000467; MolPort-001-742-592; (2S)-Naringin; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromone; 5,6,7,8,3',4'-Hexamethoxyflavone; Flavone, 5,6,7,8,3',4'-hexamethoxy; DFPMSGMNTNDNHN-ZPHOTFPESA-N; (2S)-7-[(2S,4S,5S,3R,6R)-3-((2S,6S,3R,4R,5R)-3,4,5-trihydroxy-6-methyl(2H-3,4, 5,6-tetrahydropyran-2-yloxy))-4,5-dihydroxy-6-(hydroxymethyl)(2H-3,4,5,6-tetra hydropyran-2-yloxy)]-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; Spectrum2_001697; 17784-35-9; KBio3_001922; SPBio_002513; 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)-; Nobiletin; Spectrum3_000921; ACon1_000921; SMR000059108; 7-[[2-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-2(S)-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; IDI1_000247; Prestwick0_000467; BIDD:ER0262; NSC 76751; (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl); s2329; naringenin 7-O-(alpha-L-rhamnosyl-(1,2)-beta-D-glucoside); NCGC00142617-01; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy- (9CI); MFCD00148888; BG00878320; ZINC8143604; Naringin (Naringoside); Naringoside, Naringenine-7-rhamnosidoglucoside, 10236-47-2; Prestwick3_000467; 10236-69-8; BRD-K02953697-002-03-3; cid_25075; SR-01000736681; NINDS_000247; 2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one; SR-01000736681-4; MLS000877030; MLS000759462; SPECTRUM1505268; 478-01-3; ST072162; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-chromen-4-one; AS-12929; 11032-31-8; C10112; CHEMBL451532; (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; (S)-7-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; Naringin hydrate; 236N472; 4H-1-Benzopyran-4-one, 7-((2-O-(6-deoxy-alpha-L-mannapyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl), (S)-; KBioGR_001519; 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one; DivK1c_000247; Naringenin 7-O-neohesperidoside; CC-32461; 4'5-diOH-Flavone-7-rhgluc; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-; SCHEMBL23432; (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-betaD-glucopyranoside; MLS000069459; HMS500M09; Naringenin-7-beta-neohesperidoside; (2S)-7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one; Prestwick1_000467; AKOS016034302; AI3-19008; NCGC00095703-01; Naringoside; aurantiin; C09789; Hexamethoxyflavone; SMR000156231; 109010-50-6; KBio1_000247; AC1L9CSZ; yphenyl)chroman-4-one; ZINC01531669; Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside]; MEGxp0_001877; C27H32O14; NSC76751; SPBio_001654; SR-01000736681-5; C-23277; BPBio1_000632;5,6,7,8,3',4'-hexamethoxyflavone |
分子式: | C21H22O8 |
Smiles: | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC |
成分: | HBIN037171;HBIN037172;HBIN011101 |
OB_score: | 61.669439 |
CAS_id: | 10236-47-2 |
SymMap_id: | SMIT00234 |
TCMID_id: | 15626;9509;34449 |
TCMSP_id: | MOL005828 |
PubChem_id: | 72344 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE000055 | 橘红珠 | |||||
| TCMBANKHE000081 | 柚花 | |||||
| TCMBANKHE000999 | 红芪 | to promote the drainage of pus and the growth of new tissue. | ||||
| TCMBANKHE001333 | Semen Cucumis | 甜瓜子 | ||||
| TCMBANKHE001439 | 柚叶 | |||||
| TCMBANKHE001531 | 柚根 | |||||
| TCMBANKHE002026 | Helianthus niveus | |||||
| TCMBANKHE002222 | 枳实与枳壳 | |||||
| TCMBANKHE003122 | 柚皮 | |||||
| TCMBANKHE003373 | Exocarpium Citri grandis | 化橘红 | To dispel cold, eliminate damp and phlegm, and arrest emesis or nausea./Treatment of cough, itching of the throat and profuse expectoration in colds, nausea, vomiting and epigastric distension caused by improper diet or excessive drinking. | |||
| TCMBANKHE003387 | 狗桔刺 | |||||
| TCMBANKHE003614 | Exocarpium Citri Rubrum | 橘红皮 | Treatment of cough, itching of the throat and profuse expectoration in colds, nausea, vomiting and epigastric distension caused by improper diet or excessive drinking./Treatment of cough, itching of the throat and profuse expectoration in colds, nausea, vomiting and epigastric distension caused by improper diet or excessive drinking. | |||
| TCMBANKHE003645 | Blumea glomerata | 团级艾纳香 | ||||
| TCMBANKHE003734 | radix tripterygii wilfordii | 雷公藤 | To expel wind-dampness, relieve swelling, alleviate pain and dredge the meridian passage./Rheumatoid arthritis, rheumatic arthritis, glomerulonephritis, nephropathy syndrome, erythematous lupus, dryness in eyes and mouth, Behcet’s syndrome, psoriasis, eczema, leprosy, scab sore, intractable lichen. | |||
| TCMBANKHE004020 | Citrus nobilis | 川菊 | ||||
| TCMBANKHE008690 | Pericarpium Citri Reticulatae | 陈皮 | To regulate the flow of qi, to invigorate the spleen function, to eliminate damp, and to resolve phlegm./Treatment of distension and fullness sensation in the chest and epigastrium with anorexia, vomiting and diarrhea, cough with copious phlegm. | |||
| TCMBANKHE004285 | Helianthus canescens | 灰白向日葵 | ||||
| TCMBANKHE006366 | Radix Moghaniae Philippinensis | 千斤拔 | ||||
| TCMBANKHE004575 | Citrus tankan | 蕉柑 | See Citrus chachiensis./See Citrus chachiensis . | |||
| TCMBANKHE007119 | Helianthus maximiliani | 马氏向日葵 | ||||
| TCMBANKHE007122 | Fructus Aurantii Immaturus | 枳实 | To eliminate stagnation of qi, resolve phlegm and relieve stuffiness sensation in the chest and abdomen./Shock, indigestion, ptosis of anus or uterus, cardiac failure, distention fullness in chest and abdomen, phlegm aggregation. | |||
| TCMBANKHE005239 | Fructus Aurantii | 枳壳 | To regulate the flow of qi, remove its stagnation, and alleviate distension;Treatment of distension and pain in the chest and hypochondriac regions due to stagnation of qi, indigestion with retention of phlegm and fluid, gastroptosis, prolapse of the rectum, prolapse of the uterus./Phlegm stagnation in chest and diaphragm, glomus in chest, distention in rib-side, food accumulation, retching counterflow. | |||
| TCMBANKHE005453 | Fortunella japonica | 金柑 | See Fortunella margarita ./See Fortunella margarita. | |||
| TCMBANKHE005669 | Pericarpium Citri Reticulatae Viride | 青皮 | To soothe the liver, to disintegrate stagnated qi, and to remove retained food./1. Its component limonene is an expectorant and antiasthmatic.2. Its decoction relaxes the smooth muscle of intestines, stomach, gallbladder and uterus. | |||
| TCMBANKHE005731 | 石上柏 | To clear heat and dampness, promote blood circulation and remove blood stasis: For jaundice of dampness-heat type and abdominal mass. Recently used for acute and chronic hepatitis, cirrhosis, cholecysitis, etc., also for diarrhea, desentery and leucorrhag | ||||
| TCMBANKHE008642 | Murraya paniculata [Syn. Chalcas paniculata] | 九里香 | To move qi and quicken blood, dissipate stasis and relieve pain, resolve toxin and disperse swelling, anesthetize and settle pain./Pain in stomach duct, wind-damp impediment pain, painful swelling from knocks and falls, sore and welling abscess, snake or insect bites, local anesthesia. | |||
| TCMBANKHE006736 | Radix Smilacis | 铁丝威灵仙 | ||||
| TCMBANKHE006173 | Herba Centipedae | 鹅不食草 | To relieve nasal obstruction and cough./Wind-cold common cold, cough with profuse phlegm, nasal congestion, deep-source nasal congestion and runny nose. | |||
| TCMBANKHE006580 | Calycis Melo | 瓜蒂 | Vomiting promotion/Wind stroke, epilepsy, throat impediment, indigestion of overnight food, distending pain in stomach duct, damp-heat jaundice, chronic hepatitis, cirrhosis. | |||
| TCMBANKHE007110 | Semen Citri Reticulatae | 橘核 | To regulate the flow of qi, cause subsidence of modulation, and relieve pain./Mounting qi, painful swollen testes, mammary welling abscess, lumbago, bladder qi pain. | |||
| TCMBANKHE006909 | Citrus grandis | 柚核 | To course liver and rectify qi, diffuse lung and suppress cough./Mounting qi, lung cold cough. | |||
| TCMBANKHE008948 | Citrus tankan | 蕉柑皮 | See Citrus chachiensis./See Citrus chachiensis. | |||
| TCMBANKHE008017 | 莸 | |||||
| TCMBANKHE007802 | Fortunella margarita | 金橘叶 | To soothe depressed liver qi, open stomach qi, dissipate lung qi./Dysphagia-occlusion, scrofula. | |||
| TCMBANKHE005418/YNS-102 | Rhizoma Polygoni cuspidati|Polygonum cuspidatum Sieb.et Zucc. | 虎杖 | 虎杖叶 | 云南药材标准：第一册 | 平肝潜阳，祛痰息风。用于肝阳上亢，血压偏高，头晕头昏|To dispel wind and damp, to eliminate blood stasis and alleviate pain, to relieve cough, and to resolve phlegm./Hyperlipemia, impediment pain in joints, damp-heat jaundice, toxic jaundice, child jaundice, amenorrhea, hepatitis, appendicitis, candida vaginitis, concretion and conglomeration, cough with profuse phlegm, burns and scalds, knocks and falls, swelling toxin of welling abscess and sore. | |
| TCMBANKHE006169/YEM-108 | Fructus Liquidambaris|Liquidambar formosana Hance. | 路路通|枫香树 | 路路通 | 云南民族药物志：第一卷 | To dispel wind and remove obstruction from the collaterals, to cause diuresis, and to stimulate menstrual discharge./Wind-damp impediment pain, numbness in limbs, hypertonicity of limbs, pain in stomach duct and abdomen, amenorrhea, galactostasis, edema distention fullness, eczema. | 彝族 |
| TCMBANKHE007150/YEM-237/XU-798 | Helianthus annuus|Helianthus annuus L. | 向日葵籽|向日葵 | 向日葵 | 云南民族药物志：第二卷|云南省昆明市呈贡区 | To outthrust papules, check dysentery, outthrust welling abscess and pus./Blood dysentery, welling abscess with pus swelling. | 阿昌族/傣族/德昂族/景颇族/傈僳族/藏族 |
| TCMBANKHE005716/YEM-243 | Semen Canbis;Fructus Canbis;Fructus cannabis|Cannabis sativa L. | 火麻仁;麻子仁|大麻 | 大麻 | 云南民族药物志：第二卷 | To cause Taxation.;Purging by moisterizing/Blood and liquid depletion, intestinal dry and constipation. | 阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/苗族/彝族/藏族 |
| TCMBANKHE005494/YEM-445 | Fructus Hordei Germitus|Hordeum vulgare L. | 麦芽|大麦 | 大麦 | 云南民族药物志：第三卷 | To invigo rate the function of the spleen, to regulate the function of the stomach, and to promote the flow of milk./Food accumulation, abdominal distention and diarrhea, nausea and vomiting, inappetence, galactostasis, distending pain in breast. | 佤族/彝族 |
| TCMBANKHE006922/YEM-602 | Poncirus trifoliata|Poncirus trifoliata(L.)Raf. | 枸橘叶|枳 | 枳壳 | 云南民族药物志：第三卷 | To rectify qi and dispel wind, dissipate binds and disperse swelling./Dysphagia-occlusion, wound from knocks and falls, tuberculosis and hemoptysis. Isolated stomach reflux, vomiting, globus hystericus, mounting qi. | 彝族 |
| TCMBANKHE007825/YEM-602 | Poncirus trifoliata|Poncirus trifoliata(L.)Raf. | 枸橘核|枳 | 枳壳 | 云南民族药物志：第三卷 | To stanch bleeding./Incessant intestinal wind bleeding. | 彝族 |
| TCMBANKHE006513/YEM-602 | Poncirus trifoliata|Poncirus trifoliata(L.)Raf. | 枳根皮|枳 | 枳壳 | 云南民族药物志：第三卷 | To constrain blood, relieve pain./Toothache, hemorrhoids, hematochezia. | 彝族 |
| TCMBANKHE008422/YNS-215/YEM-751/XU-85/XU-86/XU-593 | Ageratum conyzoides|Ageratum conyzoides L.|Ageratum conyzoides L. | 胜红蓟|藿香蓟 | 胜红蓟 | 云南药材标准：第六册|云南民族药物志：第四卷|广东省廉江市石岭镇 | 疏风清热，解毒止痒，止血。用于感冒发热，喉咙肿痛，疮疖，湿疹，崩漏。|To clear heat and resolve toxin, stanch bleeding, relieve pain./Common cold with fever, swelling pain in throat, hemoptysis, spontaneous external bleeding, flooding and spotting, pain in stomach duct and abdomen, wind-damp impediment pain, knocks and falls, bleeding due to external injury, swelling toxin of welling abscess and sore, eczema titillation. | 傣族/德昂族/哈尼族/基诺族/景颇族/傈僳族/佤族/瑶族/彝族/壮族 |
| TCMBANKHE005584/YEM-890 | Citrus reticulata|Citrus reticulata Blanco | 橘皮|橘 | 橘 | 云南民族药物志：第五卷 | To rectify qi and downbear counterflow, regulate center and increase appetite, dry damp and transform phlegm./Spleen-stomach qi stagnation and damp obstruction, lung qi block, cough with profuse phlegm, mammary welling abscess, indigestion, vomiting. | 阿昌族/傣族/德昂族/基诺族/景颇族/傈僳族/水族/瑶族/彝族 |
| TCMBANKHE008726/YEM-890 | Citrus reticulata|Citrus reticulata Blanco | 橘皮(陈皮)|橘 | 橘 | 云南民族药物志：第五卷 | To rectify qi and downbear counterflow, regulate center and increase appetite, dry damp and transform phlegm./Spleen-stomach qi stagnation and damp obstruction, lung qi block, cough with profuse phlegm, mammary welling abscess, indigestion, vomiting. | 阿昌族/傣族/德昂族/基诺族/景颇族/傈僳族/水族/瑶族/彝族 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000047 | AKT1 | AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA | AKT serine/threonine kinase 1 |
| TCMBANKGE000052 | TNF | DIF; TNF-alpha; TNFA; TNFSF2; TNLG1F | tumor necrosis factor |
| TCMBANKGE000121 | KCNH2 | ERG-1; ERG1; H-ERG; HERG; HERG1; Kv11.1; LQT2; SQT1 | potassium voltage-gated channel subfamily H member 2 |
| TCMBANKGE000139 | POR | CPR; CYPOR; P450R | cytochrome p450 oxidoreductase |
| TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
| TCMBANKGE000196 | FAS | ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6 | Fas cell surface death receptor |
| TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
| TCMBANKGE000202 | RUNX2 | AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA | RUNX family transcription factor 2 |
| TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
| TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
| TCMBANKGE000276 | NOS1 | IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS | nitric oxide synthase 1 |
| TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
| TCMBANKGE000290 | NQO1 | DHQU; DIA4; DTD; NMOR1; NMORI; QR1 | NAD(P)H quinone dehydrogenase 1 |
| TCMBANKGE000294 | CDKN1A | CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 | cyclin dependent kinase inhibitor 1A |
| TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
| TCMBANKGE000313 | JUN | AP-1; AP1; c-Jun; cJUN; p39 | Jun proto-oncogene, AP-1 transcription factor subunit |
| TCMBANKGE000330 | HMOX1 | HMOX1D; HO-1; HSP32; bK286B10 | heme oxygenase 1 |
| TCMBANKGE000360 | CCNA2 | CCN1; CCNA | cyclin A2 |
| TCMBANKGE000449 | CCK | - | cholecystokinin |
| TCMBANKGE000476 | NCOA2 | GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75 | nuclear receptor coactivator 2 |
| TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
| TCMBANKGE000479 | TIMP1 | CLGI; EPA; EPO; HCI; TIMP; TIMP-1 | TIMP metallopeptidase inhibitor 1 |
| TCMBANKGE000523 | BMP4 | BMP2B; BMP2B1; MCOPS6; OFC11; ZYME | bone morphogenetic protein 4 |
| TCMBANKGE000627 | BGLAP | BGP; OC; OCN | bone gamma-carboxyglutamate protein |
| TCMBANKGE000639 | HRAS | C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras | HRas proto-oncogene, GTPase |
| TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
| TCMBANKGE000784 | CALM3 | CALM; CAM1; CAM2; CAMB; CPVT6; CaM; CaMIII; HEL-S-72; LQT16; PHKD; PHKD3 | calmodulin 3 |
| TCMBANKGE000787 | VCAM1 | CD106; INCAM-100 | vascular cell adhesion molecule 1 |
| TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
| TCMBANKGE000885 | SPP1 | BNSP; BSPI; ETA-1; OPN | secreted phosphoprotein 1 |
| TCMBANKGE000903 | PTGS1 | COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS | prostaglandin-endoperoxide synthase 1 |
| TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
| TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
| TCMBANKGE001045 | CCND1 | BCL1; D11S287E; PRAD1; U21B31 | cyclin D1 |
| TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
| TCMBANKGE001079 | CYP1A1 | AHH; AHRR; CP11; CYP1; CYPIA1; P1-450; P450-C; P450DX | cytochrome P450 family 1 subfamily A member 1 |
| TCMBANKGE001085 | MAPK8 | JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c | mitogen-activated protein kinase 8 |
| TCMBANKGE001107 | NOS3 | ECNOS; eNOS | nitric oxide synthase 3 |
| TCMBANKGE001108 | BMP2 | BDA2; BMP2A; SSFSC | bone morphogenetic protein 2 |
| TCMBANKGE001118 | MMP9 | CLG4B; GELB; MANDP2; MMP-9 | matrix metallopeptidase 9 |
| TCMBANKGE001123 | CTNNB1 | CTNNB; EVR7; MRD19; NEDSDV; armadillo | catenin beta 1 |
| TCMBANKGE001131 | CASP9 | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 | caspase 9 |
| TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
| TCMBANKGE001141 | PPARA | NR1C1; PPAR; PPARalpha; hPPAR | peroxisome proliferator activated receptor alpha |
| TCMBANKGE001153 | EPHB2 | BDPLT22; CAPB; DRT; EK5; EPHT3; ERK; Hek5; PCBC; Tyro5 | EPH receptor B2 |
| TCMBANKGE001154 | CREB1 | CREB; CREB-1 | cAMP responsive element binding protein 1 |
| TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
| TCMBANKGE001164 | RAF1 | CMD1NN; CRAF; NS5; Raf-1; c-Raf | Raf-1 proto-oncogene, serine/threonine kinase |
| TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
| TCMBANKGE001170 | CDK4 | CMM3; PSK-J3 | cyclin dependent kinase 4 |
| TCMBANKGE001177 | TP53 | BCC7; BMFS5; LFS1; P53; TRP53 | tumor protein p53 |
| TCMBANKGE001185 | PPARG | CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma | peroxisome proliferator activated receptor gamma |
| TCMBANKGE001193 | GDNF | ATF; ATF1; ATF2; HFB1-GDNF; HSCR3 | glial cell derived neurotrophic factor |
| TCMBANKGE001966 | RASGRF2 | GRF2; RAS-GRF2 | Ras protein specific guanine nucleotide releasing factor 2 |
| TCMBANKGE002341 | FADD | GIG3; MORT1 | Fas associated via death domain |
| TCMBANKGE003099 | CD163 | M130; MM130; SCARI1 | CD163 molecule |
| TCMBANKGE003577 | PLA2G4A | GURDP; PLA2G4; cPLA2; cPLA2-alpha | phospholipase A2 group IVA |
| TCMBANKGE003643 | F7 | SPCA | coagulation factor VII |
| TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
| TCMBANKGE006339 | CA2 | CA-II; CAC; CAII; Car2; HEL-76; HEL-S-282 | carbonic anhydrase 2 |
| TCMBANKGE006373 | TYW1 | RSAFD1; TYW1A; YPL207W | tRNA-yW synthesizing protein 1 homolog |
| TCMBANKGE009802 | DHFR | DHFRP1; DYR | dihydrofolate reductase |
| TCMBANKGE009851 | FAP | DPPIV; FAPA; FAPalpha; SIMP | fibroblast activation protein alpha |
| TCMBANKGE009863 | MTRR | MSR; cblE | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
| TCMBANKGE010388 | PPARD | FAAR; NR1C2; NUC1; NUCI; NUCII; PPARB | peroxisome proliferator activated receptor delta |
| TCMBANKGE010916 | CCNE1 | CCNE; pCCNE1 | cyclin E1 |
| TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
| TCMBANKGE011356 | NDOR1 | CIAE1; NR1; bA350O14.9 | NADPH dependent diflavin oxidoreductase 1 |
| TCMBANKGE013874 | GHSR | GHDP | growth hormone secretagogue receptor |
| TCMBANKGE015090 | CYP1A2 | CP12; CYPIA2; P3-450; P450(PA) | cytochrome P450 family 1 subfamily A member 2 |
滇ICP备16009434号-1 |
Dai SX Lab